Ronald Swanson, Senior Director, Janssen R&D Will Give a Featured Presentation at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 – Feb 1, 2013 in San Diego, CA)
Thomas Platts-Mills, will present‘The Significance of IgE Antibodies to Galactose-alpha -1, 3-Galactose (alpha-gal)’ at GTC’s 2nd Allergy & Respiratory Drug Discovery Conference taking place in San Diego, CA on January 31 – February 1, 2013.
M. J. Hampel, MPH, MBA, Senior Associate Director, Disease Specific Certification, The Joint Commission will serve as a keynote speaker at the Healthcare Centers of Excellence Summit.
GTC is proud to announce the Pre-Summit Workshop, “Developing a Sustainable Healthcare Business Model” to be held on May 15th, 2012 and will directly precede the Healthcare Centers of Excellence Summit at the Meliá Atlanta Hotel in Atlanta, GA
T. (Teo) Forcht Dagi, Partner at HLM Venture Partners will give a featured presentation about “Funding Opportunities and What Venture Capitalists Seek in a Diabetes Investment” .
Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism at Boehringer Ingelheim, Ingelheim, Germany, will be giving a plenary keynote presentation at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA)
Andrew Merron Ph.D., Biosimilars Advisory Service Product Director at BioTrends (a Decision Resources Company), will be giving a featured presentation at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA)